Invesco vs TPG
Add, change or remove companies; up to four.
The short version
- Invesco is the larger business, with $6.4B of revenue in fiscal 2025 against $4.7B for TPG.
- TPG grew revenue faster (33.4%, against 5.1%).
- TPG earned a higher return on the capital invested in it (15.2%, against β3.8%).
| Latest fiscal year | IVZ Β· FY25 | TPG Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $12.8B | $17.2B |
| Revenue | $6.4B | $4.7B |
| Free cash flow | $1.4B | β |
| Net income | β$726M | $185M |
| Growth | ||
| Revenue growth | 5.1% | 33.4% |
| 5-year growth | 0.7% | β |
| Share count change | β0.6% | 2.6% |
| Profitability | ||
| Gross margin | β | β |
| Operating margin | β10.9% | β |
| Net margin | β11.4% | 4.0% |
| FCF margin | 22.6% | β |
| Return on capital | β3.8% | 15.2% |
| Return on equity | β5.4% | 4.8% |
| Balance sheet | ||
| Net debt | $788M | $896M |
| Net debt / EBITDA | β | 1.0x |
| Dividends and buybacks | $501M | $0.0M |
| Valuation & quality | ||
| P/E | β | 66.6x |
| Piotroski F-score | β | β |
Revenue
FY16
IVZ $4.7B
TPG β
FY17
IVZ $5.2B
TPG β
FY18
IVZ $5.3B
TPG β
FY19
IVZ $6.1B
TPG β
FY20
IVZ $6.1B
TPG β
FY21
IVZ $6.9B
TPG β
FY22
IVZ $6.0B
TPG $2.0B
FY23
IVZ $5.7B
TPG $2.4B
FY24
IVZ $6.1B
TPG $3.5B
FY25
IVZ $6.4B
TPG $4.7B
IVZ
TPG
Operating margin
FY16
IVZ 24.3%
TPG β
FY17
IVZ 24.8%
TPG β
FY18
IVZ 22.7%
TPG β
FY19
IVZ 13.2%
TPG β
FY20
IVZ 15.0%
TPG β
FY21
IVZ 25.9%
TPG β
FY22
IVZ 21.8%
TPG β
FY23
IVZ β7.6%
TPG β
FY24
IVZ 13.7%
TPG β
FY25
IVZ β10.9%
TPG β
IVZ
TPG
Free cash flow
FY16
IVZ $506M
TPG β
FY17
IVZ $1.0B
TPG β
FY18
IVZ $726M
TPG β
FY19
IVZ $992M
TPG β
FY20
IVZ $1.1B
TPG β
FY21
IVZ $969M
TPG β
FY22
IVZ $510M
TPG β
FY23
IVZ $1.1B
TPG β
FY24
IVZ $1.1B
TPG β
FY25
IVZ $1.4B
TPG β
IVZ
TPG
Return on capital
FY16
IVZ 9.6%
TPG β
FY17
IVZ 11.9%
TPG β
FY18
IVZ 9.7%
TPG β
FY19
IVZ 4.8%
TPG β
FY20
IVZ 4.5%
TPG β
FY21
IVZ 8.9%
TPG β
FY22
IVZ 6.0%
TPG β
FY23
IVZ β2.2%
TPG 1.9%
FY24
IVZ 4.1%
TPG 1.1%
FY25
IVZ β3.8%
TPG 15.2%
IVZ
TPG
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.